4th Patient on M.S. Drug May Have Brain Infection
Fri, 03 Jun 2005 03:00 AM EST
By ANDREW POLLACK... Shares of Biogen Idec and Elan fell yesterday on news that a fourth patient may have developed the life-threatening brain infection that prompted the companies to halt sales of their multiple sclerosis drug Tysabri earlier this year. ...
Related Topics
- Brain Tumor
- Brain Cancer
- Patient Issues
- Brain Aneurysm
- Viral Infections
- Brain Diseases
- Personal Medical Records
- Drug Information
- Traumatic Brain Injury
- Bacterial Infection
- Brain Injury
- Bacterial Infections
- Fungal Infections & Diseases
- Fungal Infections
- Ear Infections
- Yeast Infections
- Infections
- Drug Safety
- Prescription Drugs
- Infection (bladder)

Not Signed In -


